BBOT

BridgeBio Oncology
BBOT

Overview Fund Trends Analyst Outlook Journalist POV

32 hedge funds and large institutions have $173M invested in BridgeBio Oncology in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0.38% more ownership

Funds ownership: 86.59% → 86.97% (+0.38%)

Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$520K
2
+$367K
3
+$126K
4
Citadel Advisors
Citadel Advisors
Florida
+$73.7K
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$27.3K

Top Sellers

1
-$1.25M
2
-$418K
3
-$11.9K
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$840
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$42
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$30.5M
2
$15.7M
3
$14.7M
4
$14.1M
5
$12M
6
$11.4M
7
$7.4M
8
$6.3M
9
$5.39M
10
$5.25M
11
$5.25M
12
$5.25M
13
$4.99M
14
$4.24M
15
$4.2M
16
$3.15M
17
$2.7M
18
$2.63M
19
$2.63M
20
$2.11M
21
$1.99M
22
$1.96M
23
$1.94M
24
$1.9M
25
$1.52M
1
2